Beijing, China

Dan Jiang

USPTO Granted Patents = 8 


 

Average Co-Inventor Count = 6.1

ph-index = 4

Forward Citations = 68(Granted Patents)


Company Filing History:


Years Active: 2012-2016

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Dan Jiang: Innovator in Pharmaceutical and Language Technologies

Introduction

Dan Jiang is a prominent inventor based in Beijing, China. He has made significant contributions to the fields of pharmaceuticals and language processing technologies. With a total of 8 patents, his work has had a considerable impact on both industries.

Latest Patents

One of Dan Jiang's latest patents is titled "Thiazine amide derivative and pharmaceutical composition and use thereof." This invention relates to a thiazine amide derivative and its pharmaceutical applications, particularly in the prevention or treatment of neurodegenerative diseases. The patent details a compound of formula I, along with methods for preparing the compound and pharmaceutical compositions containing it. Another notable patent focuses on "Translating between spoken and written language." This invention provides techniques for converting spoken speech into written text, utilizing speech recognition and formal utterance mapping.

Career Highlights

Throughout his career, Dan Jiang has worked with notable companies such as Nuance Communications, Inc. and IBM. His experience in these organizations has allowed him to develop innovative solutions that bridge the gap between technology and human communication.

Collaborations

Dan has collaborated with esteemed colleagues, including Dimitri Kanevsky and Sara H Basson, who have contributed to his research and development efforts.

Conclusion

Dan Jiang's innovative work in pharmaceuticals and language technologies showcases his dedication to advancing these fields. His patents reflect a commitment to improving health outcomes and enhancing communication through technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…